ÂÜÀòÂÒÂ×

With more than 25 years of experience in the biotechnology industry, Jenny is dedicated to building Carrick’s innovative portfolio and accessing potential new treatments that can have a major impact on the lives of patients.

She is a former Global Transaction Director for AstraZeneca where she had responsibility for leading the evaluation and negotiation of business development transactions including in-licensing, out-licensing, collaborations, M&A and divestments across a number of therapy areas including Oncology and Respiratory and Inflammation.

Previous positions at AstraZeneca included Head of Business Development Japan based in Osaka, responsible for all Japanese partnering activities and Head of transactions China and Asia, based in Shanghai.

Jenny has a broad commercial and finance background and is a qualified Chartered Global Management Accountant (CGMA).